Core Points - A shareholder has filed a securities class action lawsuit on behalf of investors who purchased or acquired common stock of MoonLake Immunotherapeutics between March 10, 2024, and September 29, 2025 [1] - The lawsuit alleges that the defendants made misrepresentations regarding the company's sole drug candidate, sonelokimab (SLK), which was claimed to be superior to competing monoclonal antibody drugs [3] Legal Proceedings - Investors wishing to serve as lead plaintiff must file papers by December 15, 2025, and representation is on a contingency fee basis, meaning shareholders pay no fees or expenses [4] - The law firm Bernstein Liebhard LLP has a history of recovering over $3.5 billion for clients and has been recognized for its success in litigating class actions [5]

Core Viewpoint - A shareholder has filed a securities class action lawsuit against WPP plc, alleging misrepresentations regarding the company's media arm and its ability to handle macroeconomic challenges [1][2]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who purchased WPP common stock between February 27, 2025, and July 8, 2025 [1]. - Defendants are accused of making false statements about WPP's media arm, specifically its preparedness to face ongoing macroeconomic challenges [2]. Group 2: Legal Process - Interested parties wishing to serve as lead plaintiff must file by December 8, 2025, with the role involving representation of other class members in the litigation [3]. - Shareholders can remain absent class members without taking action, and all legal representation is on a contingency fee basis, meaning no upfront fees or expenses for shareholders [3]. Group 3: Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has represented large public and private pension funds [4]. - The firm has been recognized multiple times for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" and listed in The Legal 500 for sixteen consecutive years [4].

NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, inclusive. Should You Join This Class Action Lawsuit? Do you, or did you, own shares of Nutex Health Inc. (NASDAQ: NUTX)?Did you purchase your shares between August 8, 2024 and August 14, ...

Core Points - A shareholder has filed a securities class action lawsuit on behalf of investors who purchased or acquired Lantheus Holdings, Inc. securities between February 26, 2025, and August 5, 2025 [1] - The lawsuit alleges that the defendants made misrepresentations regarding the competitive position of Lantheus' key Radiopharmaceutical Oncology product, Pylarify [2] Legal Proceedings - Investors wishing to serve as lead plaintiff must file papers by November 10, 2025, and representation is on a contingency fee basis, meaning shareholders pay no fees or expenses [3] - The law firm Bernstein Liebhard LLP has a history of recovering over $3.5 billion for clients and has been recognized for its success in litigating class actions [4]

Core Viewpoint - Tronox Holdings PLC is facing a securities fraud class action lawsuit alleging misrepresentations regarding demand for its pigment and zircon products, impacting investors who purchased shares between February 12, 2025, and July 30, 2025 [3]. Group 1: Lawsuit Details - The lawsuit was filed in the United States District Court for the District of Connecticut on behalf of investors who acquired Tronox common stock during the specified period [3]. - The allegations include violations of the Securities Exchange Act of 1934 against the Company and certain senior officers [3]. Group 2: Legal Actions and Deadlines - Investors wishing to serve as lead plaintiffs must file necessary documents by November 3, 2025 [4]. - Participation as a lead plaintiff is not required to share in any potential recovery, and all representation is on a contingency fee basis, meaning shareholders incur no fees or expenses [4]. Group 3: Law Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has represented large public and private pension funds [5]. - The firm has been recognized multiple times in The National Law Journal's "Plaintiffs' Hot List" and has been listed in The Legal 500 for sixteen consecutive years [5].

Core Viewpoint - Nutex Health Inc. is facing a securities fraud class action lawsuit, with allegations of materially false and misleading statements regarding its business and operations [3]. Group 1: Lawsuit Details - The lawsuit was filed in the United States District Court for the Southern District of Texas on behalf of investors who purchased Nutex securities between August 8, 2024, and August 14, 2025 [3]. - The lawsuit alleges violations of the Securities Exchange Act of 1934 against Nutex and certain senior officers [3]. Group 2: Legal Actions and Deadlines - Investors wishing to serve as lead plaintiffs must file papers by October 21, 2025 [4]. - Serving as a lead plaintiff is not required to share in any recovery, and all representation is on a contingency fee basis, meaning shareholders pay no fees or expenses [4]. Group 3: Law Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for its clients since 1993 and has represented large public and private pension funds [5]. - The firm has been recognized multiple times in The National Law Journal's "Plaintiffs' Hot List" and has been listed in The Legal 500 for sixteen consecutive years [5].

Do you, or did you, own shares of Fluor Corporation (NYSE: FLR)?Did you purchase your shares between February 18, 2025 and July 31, 2025, inclusive?Did you lose money in your investment in Fluor Corporation?Do you want to discuss your rights? NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Fluor Corporation (“Fluor” or the “Company”) (NYSE: FLR) investors of an upcoming deadline involving a securities fraud class action lawsuit co ...

Core Viewpoint - KinderCare Learning Companies, Inc. is facing a securities fraud class action lawsuit related to its initial public offering in October 2024, alleging misrepresentations about the child care services offered by the company [3]. Group 1: Lawsuit Details - A lawsuit has been filed in the United States District Court for the District of Oregon on behalf of investors who purchased or acquired KinderCare common stock during or traceable to the October 2024 IPO [3]. - The lawsuit alleges violations of the Securities Act of 1933 against KinderCare and certain senior officers, claiming that they made misrepresentations regarding the company's child care offerings [3]. Group 2: Legal Actions and Deadlines - Investors wishing to serve as lead plaintiffs must file necessary documents by October 14, 2025, with the lead plaintiff acting on behalf of other class members in directing the litigation [4]. - Participation as a lead plaintiff is not required to share in any potential recovery, and all representation is on a contingency fee basis, meaning shareholders incur no fees or expenses [4]. Group 3: Law Firm Background - Bernstein Liebhard LLP, the law firm handling the case, has recovered over $3.5 billion for clients since 1993 and has represented both individual investors and large public and private pension funds [5]. - The firm has been recognized multiple times for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for sixteen consecutive years [5].

Do you, or did you, own shares of Lantheus Holdings, Inc. (NASDAQ: LNTH)?Did you purchase your shares between February 26, 2025 and August 5, 2025, inclusive?Did you lose money in your investment in Lantheus Holdings, Inc.?Do you want to discuss your rights? NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) investors of an upcoming deadline involving a securities f ...

Core Viewpoint - A securities fraud class action lawsuit has been filed against C3.ai, Inc. alleging misrepresentations regarding the company's business and the impact of the CEO's health on its operations [2][3]. Group 1: Lawsuit Details - The lawsuit was initiated in the United States District Court for the Northern District of California on behalf of investors who acquired C3 securities between February 26, 2025, and August 8, 2025 [2]. - Allegations include that the CEO's health significantly affected C3 AI's ability to close deals and that management failed to mitigate this impact, hindering the company's profit and growth potential [3]. Group 2: Legal Representation - Investors wishing to serve as lead plaintiffs must file by October 21, 2025, with the option to remain absent class members without affecting their ability to share in any recovery [4]. - All legal representation is on a contingency fee basis, meaning shareholders incur no fees or expenses [4]. Group 3: Law Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has represented large public and private pension funds [5]. - The firm has been recognized multiple times for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" and listed in The Legal 500 for sixteen consecutive years [5].